Management of High Cholesterol in Young Adults

JAMA Cardiology

EMBARGOED FOR RELEASE: 1:35 P.M. (ET), MONDAY, NOVEMBER 15, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2021.4983?guestAccessKey=ea568507-213b-450b-b174-bf84e9164ff8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111521

 

What the Study Did: This study of 17,000 adults ages 20 to 39 found that fewer than 1 in 3 with severe high cholesterol achieved guideline-directed low-density lipoprotein cholesterol (LDL-C) reduction and nearly 1 in 4 had an LDL-C level persistently at levels indicating statin therapy, and fewer than half of these patients were prescribed lipid lowering therapy.

Authors: Michael C. Honigberg, M.D., M.P.P., of Massachusetts General Hospital in Boston, is the corresponding author.

 

(doi:10.1001/jamacardio.2021.4983)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.